** Shares of Adherium ADR.AX rise as much as 132.5% to
A$0.093, set for their best day, if gains hold
** The medical tech co says nasal device Hailie Smartinhaler
has received clearance from the U.S. Food and Drug
Administration for use with AstraZeneca's Airsupra and Breztri
inhalation devices
** Stock at its highest level since Sept 23, 2022
** About 7.6 mln shares change hands, compared with the
30-day average volume of 64,438
** ADR stock down 28.6% YTD, as of last close
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))